News and features related to Prostate cancer

1. Prostate cancer drug U-turn welcomed
   

   16th May 2012 - There was disappointment from cancer charities when NICE said it was planning to reject abiraterone (Zytiga) for prostate cancer; now the regulator has changed its mind. The National Institute for Health and Clinical Excellence (NICE) now says abiraterone is an effective treatment fo

   Read Full Article
2. New treatment for prostate cancer shows promise
   

   17th April 2012 - A new treatment for prostate cancer has been carried out in London which holds out the prospect of being more effective while involving fewer side-effects. Doctors at University College Hospital used high-intensity focused ultrasound (HIFU) to treat small patches of cancer cells, a

   Read Full Article
3. Cycling can trigger warning sign of prostate cancer
   

   9th March 2012 - Many doctors are unaware that keen cyclists can have raised levels of a protein which is an important indicator for detecting prostate cancer, says a leading consultant urologist. A failure to check whether patients spend long spells in the saddle is resulting in otherwise healthy m

   Read Full Article
4. Prostate cancer drug 'too expensive'
   

   2nd February 2012 - A new medication to treat advanced prostate cancer is too costly when set against the benefits to patients, the National Institute for Health and Clinical Excellence (NICE) has said in draft guidance. NICE said it was "disappointed" not to be able to recommend abiraterone, also k

   Read Full Article
5. No evidence for benefits of prostate cancer screening
   

   Prostate cancer occurs when some of the cells in a man’s prostate gland begin to grow out of control, invading and destroying healthy cells. As men get older their chances of getting cancer of the prostate rise. To detect prostate cancer, doctors often use a test called a digital rectal exam (DRE) t

   Read Full Article
6. Prostate cancer risk from vitamin E supplements
   

   Previous research had suggested that selenium and vitamin E might reduce the risk of prostate cancer. To find out more, researchers studied more than 35,000 healthy men aged 50 years or older, with an average risk of prostate cancer. They were randomly chosen to take either selenium, vitamin E, a co

   Read Full Article
7. Prostate cancer drug rejected
   

   30th September 2011 - Medication that can extend the lives of men with advanced prostate cancer should be rejected for use in the NHS, the National Institute for Clinical Excellence (NICE) says in draft guidance. NICE said that cabazitaxel (Jevtana), in combination with prednisone or prednisolone, w

   Read Full Article
8. New prostate cancer drug launched
   

   21st September 2011 - A new medication to treat advanced prostate cancer has been launched on the UK market following licensing by the European Medicines Agency. Abiraterone acetate, which is taken as a daily pill, is used to treat men who have already undergone chemotherapy. Recent figures show tha

   Read Full Article
9. Prostate cancer urine test
   

   4th August 2011 - Prostate cancer screening biopsies can be painful and give inconclusive results, but now a painless urine test could help predict when high prostate-specific antigen (PSA) levels suggest a   prostate cancer or a more benign condition. A new study reports on the test which looks for

   Read Full Article
10. Brisk walking may help after prostate cancer
    

    Prostate cancer is one of the most common cancers affecting men. Despite this, we don’t know much about what causes it, or whether there’s anything you can do to avoid it. Treatments for prostate cancer include surgery, chemotherapy, radiotherapy, and hormone therapy. Recently, researchers have look

    Read Full Article